Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
HPV and/or Cervical Cancer Vaccines 2010 NIAID 5R01AI073713-03 Behavioral and Virologic Impact of HPV Immunization KAHN, JESSICA CHILDREN'S HOSPITAL MED CTR (CINCINNATI) OH $516,831
HPV and/or Cervical Cancer Vaccines 2010 NIGMS 1SC2AI090922-01 Anogenital HPV Infection in a Population-Based Sample of Puerto Rican Women ORTIZ, ANA UNIVERSITY OF PUERTO RICO MED SCIENCES PR $141,888
HPV and/or Cervical Cancer Vaccines 2010 NIDCR 5R01DE019075-03 Develop an Oral HIV Vaccine Using Papilloma Virus-Like Particles as a Vector QIAO, LIANG LOYOLA UNIVERSITY CHICAGO IL $345,493
HPV and/or Cervical Cancer Vaccines 2010 NCI 5R13CA132461-03 International Papillomavirus Conferences 2007-12 PIRISI-CREEK, LUCIA UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA SC $13,000
HPV and/or Cervical Cancer Vaccines 2010 NIAID 2R01AI038382-17 HPV Capsid Antibodies GALLOWAY, DENISE FRED HUTCHINSON CANCER RESEARCH CENTER WA $405,044
HPV and/or Cervical Cancer Vaccines 2010 NCI 2R01CA074397-11 HPV VLP AND ANTIGEN PRESENTING CELLS KAST, WIJBE UNIVERSITY OF SOUTHERN CALIFORNIA CA $326,284
HPV and/or Cervical Cancer Vaccines 2010 NIAID 1K23AI077759-01A1 Post-Vacc. HPV Genotype Distr. Among HIV+ and HIV- Young Women in S. Africa ADLER, DAVID UNIVERSITY OF ROCHESTER NY $125,838
HPV and/or Cervical Cancer Vaccines 2010 NCI 5R01CA059655-17 Regulation of Human Papillomavirus Gene Expression LAIMINS, LAIMONIS NORTHWESTERN UNIVERSITY IL $311,901
HPV and/or Cervical Cancer Vaccines 2010 NIAID 5R01AI072204-04 Cervical, Anal, and Oral HPV Persistence and Risk Factors Among Adolescent Girls DIAZ, ANGELA MOUNT SINAI SCHOOL OF MEDICINE NY $807,540
HPV and/or Cervical Cancer Vaccines 2010 NCI 2R01CA098803-06A1 Natural History of HPV Infection in Men: The HIM Study GIULIANO, ANNA H. LEE MOFFITT CANCER CTR & RES INST FL $2,105,062
HPV and/or Cervical Cancer Vaccines 2010 NCI 5R01CA069632-12 Cancer immunotherapy with a live recombinant vaccine PATERSON, YVONNE UNIVERSITY OF PENNSYLVANIA PA $326,923
HPV and/or Cervical Cancer Vaccines 2010 NCI 5R01CA118790-04 Mechanisms of Papillomavirus Neutralization RODEN, RICHARD JOHNS HOPKINS UNIVERSITY MD $280,440
HPV and/or Cervical Cancer Vaccines 2010 NCI 5U01CA078527-13 Persistent HPV in Women at Risk for Cervix Cancer BURK, ROBERT ALBERT EINSTEIN COL OF MED YESHIVA UNIV NY $596,586
HPV and/or Cervical Cancer Vaccines 2010 NCI 5R01CA136847-02 Diindolylmethane enhances the efficacy of preventive vaccines in an HPV transgeni SEPKOVIC, DANIEL HACKENSACK UNIVERSITY MEDICAL CENTER NJ $361,673
HPV and/or Cervical Cancer Vaccines 2010 NCI 5R01CA037667-26 Mechanisms in Polyoma and Papillomavirus Assembly GARCEA, ROBERT UNIVERSITY OF COLORADO AT BOULDER CO $343,757
HPV and/or Cervical Cancer Vaccines 2010 NIAID 5R21AI083962-02 Development of a Primate Model for Genital Papillomavirus Infection BURK, ROBERT ALBERT EINSTEIN COL OF MED YESHIVA UNIV NY $231,123
HPV and/or Cervical Cancer Vaccines 2010 NCI 1P50CA148110-01 6234 ENHANCING CERVICAL CANCER PREVENTION STRATEGIES AMONG HOPI WOMEN AND ADOLES... GONZALES, ANGELA CORNELL UNIVERSITY NY $183,596
HPV and/or Cervical Cancer Vaccines 2010 NCI 2P50CA105632-06 6484 HPV IMMUNIZATION RESPONSE AND STRESS RUFFIN, MACK UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $147,317
HPV and/or Cervical Cancer Vaccines 2010 NCI 2P50CA105632-06 6485 STUDY TO EXAMINE PATIENT/PROVIDER SYSTEMS (STEPS) PASKETT, ELECTRA OHIO STATE UNIVERSITY OH $145,551
HPV and/or Cervical Cancer Vaccines 2010 NIAID 5R01AI076440-03 Recommendation of HPV Vaccination among U.S. Physicians VADAPARAMPIL, SUSAN H. LEE MOFFITT CANCER CTR & RES INST FL $561,004
HPV and/or Cervical Cancer Vaccines 2010 NICHD 5R03HD058771-02 Disclosure of High-Risk HPV Infection to Sex Partners of Young Men KOUTSKY, LAURA UNIVERSITY OF WASHINGTON WA $74,727
HPV and/or Cervical Cancer Vaccines 2010 NIAID 5F31AI080187-02 Acceptability and feasbility of the HPV vaccine schedule in female sex workers BROWN, BRANDON JOHNS HOPKINS UNIVERSITY MD $41,380
HPV and/or Cervical Cancer Vaccines 2010 NIAID 1P01AI083224-01A1 5210 Natural History of HPV Infections in Mid-adult Women WINER, RACHEL UNIVERSITY OF WASHINGTON WA $1,071,079
HPV and/or Cervical Cancer Vaccines 2010 NCI 5R01CA125069-04 Effects of Mindfulness-Based Stress Reduction (MBSR) on Immune Response to HPV FANG, CAROLYN FOX CHASE CANCER CENTER PA $605,223
HPV and/or Cervical Cancer Vaccines 2010 NCI 5R01CA133749-03 A Phase I Study to Evaluate the Safety and Immunogenicity of HPV 16 L2 11-200 HUH, WARNER UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $329,787
HPV and/or Cervical Cancer Vaccines 2010 NCI 5R03CA144734-02 HPV vaccine practices among Physicians Serving High Risk, Minority Populations ARAGONES, ABRAHAM SUNY DOWNSTATE MEDICAL CENTER NY $79,542
HPV and/or Cervical Cancer Vaccines 2010 NIMHD 5R43MD005198-02 A Multicultural, Multilingual HPV Vaccine Education DVD for Diverse Populations VALDEZ, ARMANDO VALDEZ AND ASSOCIATES CA $66,141
HPV and/or Cervical Cancer Vaccines 2010 NIAID 1R03AI090499-01 Physicians' Intentions to Administer HPV Vaccine KULCZYCKI, ANDRZEJ UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $73,250
HPV and/or Cervical Cancer Vaccines 2010 NCI 1R01CA143130-01A1 Understanding and Enhancing T-Cell Responses to high Risk Human Papillomaviruses NAKAGAWA, MAYUMI UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK AR $774,808
HPV and/or Cervical Cancer Vaccines 2010 NIAID 1R21AI085380-01A1 Laser treatment to enhance therapeutic HPV DNA vaccine potency WU, T.-C. JOHNS HOPKINS UNIVERSITY MD $213,471
HPV and/or Cervical Cancer Vaccines 2010 NICHD 1R21HD062929-01A1 School Mandates for Human Papillomavirus Vaccination: Use of an Agent-Based Model DEMPSEY, AMANDA UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $189,310
HPV and/or Cervical Cancer Vaccines 2010 NCI 1R43CA154078-01 Development of an L2-based HPV vaccine to generate broad immunity OTT, GARY DYNAVAX TECHNOLOGIES CORPORATION CA $298,625
HPV and/or Cervical Cancer Vaccines 2010 NCI N01CP11005-17-0-1 HPV TYPE 16 VACCINE TRIAL IN COSTA RICA HERRERO, ROLANDO FUNDACION INCIENSA COSTA $4,394,576
HPV and/or Cervical Cancer Vaccines 2010 OD N01CP11005-17-0-1 HPV TYPE 16 VACCINE TRIAL IN COSTA RICA HERRERO, ROLANDO FUNDACION INCIENSA COSTA $400,000
HPV and/or Cervical Cancer Vaccines 2010 NCI 1U54CA153708-01 7778 Research Project PATEL, KUSHAL MEHARRY MEDICAL COLLEGE TN $452,254
HPV and/or Cervical Cancer Vaccines 2010 NCI 5P50DE019032-09 0003 HPV VACCINE THERAPY AND CORRELATES OF RESPONSE IN HEAD AND NECK SQUAMOUS CELL PAI, SARA JOHNS HOPKINS UNIVERSITY MD $27,651
HPV and/or Cervical Cancer Vaccines 2010 NIDCR 5P50DE019032-09 0003 HPV VACCINE THERAPY AND CORRELATES OF RESPONSE IN HEAD AND NECK SQUAMOUS CELL PAI, SARA JOHNS HOPKINS UNIVERSITY MD $344,409
HPV and/or Cervical Cancer Vaccines 2010 NIAID 5U19AI084081-02 6477 Population Effectiveness of HPV Vaccination on Cervical Cancer Prevention in the WHEELER, COSETTE UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR NM $579,300
HPV and/or Cervical Cancer Vaccines 2010 NIAID 5U19AI084081-02 6478 Web enhanced adoption of HPV vaccine in minority communities WOODALL, W UNIVERSITY OF NEW MEXICO NM $464,498
HPV and/or Cervical Cancer Vaccines 2010 NICHD 1ZIAHD008900-01 Safety and Immunogenicity of Gardasil post stem cell transplantation STRATTON, PAMELA NIH $91,129
HPV and/or Cervical Cancer Vaccines 2010 NCI 1ZIABC009052-21 Papillomavirus Virion Proteins and Vaccines SCHILLER, JOHN NIH $1,702,735
HPV and/or Cervical Cancer Vaccines 2010 NCI 1ZIABC010579-07 Papillomavirus Virion Proteins and Vaccines LOWY, DOUGLAS NIH $1,133,390
HPV and/or Cervical Cancer Vaccines 2010 NCI 1ZIABC010756-05 Development a combined prophylactic and therapeutic cervical cancer vaccine u KHLEIF, SAMIR NIH $69,235
HPV and/or Cervical Cancer Vaccines 2010 NCI 1ZIABC010907-03 Papillomavirus Infectious Entry BUCK, CHRISTOPHER NIH $126,187
HPV and/or Cervical Cancer Vaccines 2010 NCI 1ZIACP010210-01 HPV, cervical neoplasia, and vaccination HILDESHEIM, ALLAN NIH $1,524,463
HPV and/or Cervical Cancer Vaccines 2010 NCRR 5M01RR000188-46 6610 A5240 (VERSION 10) A PHASE II STUDY TO EVALUATE THE IMMUNOGENICITY AND SAFETY SHEARER, WILLIAM BAYLOR COLLEGE OF MEDICINE TX $15,646
HPV and/or Cervical Cancer Vaccines 2010 NCRR 5M01RR000865-37 6983 A SINGLE ARM, OPEN-LABEL PILOT TRIAL OF THE SAFETY AND IMMUNOGENICITY OF A QUADR MITSUYASU, RONALD UNIVERSITY OF CALIFORNIA LOS ANGELES CA $94,148
HPV and/or Cervical Cancer Vaccines 2010 NCI 5P50CA098252-07 7978 L1 capsomeres as a next generation preventive HPV vaccine GARCEA, ROBERT JOHNS HOPKINS UNIVERSITY MD $310,410
HPV and/or Cervical Cancer Vaccines 2010 NCI 5P50CA098252-07 7979 Development of a Pan-Oncogenic HPV Preventive Vaccine RODEN, RICHARD JOHNS HOPKINS UNIVERSITY MD $310,397
HPV and/or Cervical Cancer Vaccines 2010 NCI 5P50CA098252-07 7980 A phase I trial to assess the immunogenicity, safety, tolerability and efficacy o TRIMBLE, CORNELIA JOHNS HOPKINS UNIVERSITY MD $210,262
HPV and/or Cervical Cancer Vaccines 2010 NCI 5P50CA098252-07 7981 A phase I trial to assess the safety and immunogenicity of repeated, cluster part ALVAREZ, RONALD JOHNS HOPKINS UNIVERSITY MD $301,914
HPV and/or Cervical Cancer Vaccines 2010 NCI 5P50CA098252-07 7985 Immunology Core VISCIDI, RAPHAEL JOHNS HOPKINS UNIVERSITY MD $210,854


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer